{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:41:19Z","timestamp":1774647679791,"version":"3.50.1"},"reference-count":70,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The aim of this study was to determine the optimal management of patients with propylthiouracil (PTU) hepatotoxicity.<\/jats:p>\n               <jats:p>A MEDLINE search for English language cases of PTU hepatotoxicity between 1966 and April 1996 was performed, and additional cases were cross-referenced. Twenty-seven cases were selected based on the availability of information on patient management after the onset of hepatotoxicity. Eighty-five percent of the selected cases met this criterion. A detailed summary of the management of two cases of PTU hepatotoxicity at our institutions is also provided.<\/jats:p>\n               <jats:p>Although most patients recovered once PTU was stopped, seven patients died. Patients with PTU hepatotoxicity who survived were more likely to have received 131I during the course of their illness than those who died (P &amp;lt; 0.03, by Fisher\u2019s exact test). In our two patients, hyperbilirubinemia was linearly associated with progressively decreasing T4 levels (r = 0.91; P &amp;lt; 0.001) despite the presence of clinical thyrotoxicosis in one of the patients. These findings demonstrate the need for appropriate clinical evaluation and treatment of thyroid disease during the course of hepatotoxicity. Additionally, we report the first pediatric patient with PTU hepatotoxicity to undergo liver transplantation. The emerging role of liver transplantation in these patients is discussed.<\/jats:p>","DOI":"10.1210\/jcem.82.6.4011","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:01:43Z","timestamp":1389200503000},"page":"1727-1733","source":"Crossref","is-referenced-by-count":13,"title":["Fifty Years of Experience with Propylthiouracil-Associated Hepatotoxicity: What Have We Learned?1"],"prefix":"10.1210","volume":"82","author":[{"given":"Katherine V.","family":"Williams","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Departments of Medicine (K.V.W., L.A.B.), Pittsburgh, Pennsylvania 15261"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Nayak","sequence":"additional","affiliation":[{"name":"Pediatrics (S.N., D.B.), Pittsburgh, Pennsylvania 15261"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy","family":"Becker","sequence":"additional","affiliation":[{"name":"Pediatrics (S.N., D.B.), Pittsburgh, Pennsylvania 15261"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Reyes","sequence":"additional","affiliation":[{"name":"The Thomas E. Starzl Transplantation Institute (J.R.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn A.","family":"Burmeister","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Departments of Medicine (K.V.W., L.A.B.), Pittsburgh, Pennsylvania 15261"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071613333519800_R1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/jama.1947.02890070024006","article-title":"Agranulocytosis and hepatocellular jaundice.","volume":"135","author":"Livingston","year":"1947","journal-title":"JAMA"},{"key":"2020071613333519800_R2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/00007611-199409000-00018","article-title":"Hepatotoxicity from propylthiouracil.","volume":"87","year":"1994","journal-title":"South Med J"},{"key":"2020071613333519800_R3","first-page":"85","article-title":"Propylthiouracil hepatotoxicity: a review and case presentation.","volume":"32","year":"1993","journal-title":"Clin Pediatr"},{"key":"2020071613333519800_R4","first-page":"75","article-title":"Propylthiouracil-associated hepatitis.","volume":"83","year":"1991","journal-title":"Journal of the National Medical Association"},{"key":"2020071613333519800_R5","first-page":"470","article-title":"Propylthiouracil-induced hepatic failure and encephalopathy in a child.","volume":"24","year":"1990","journal-title":"DICP Ann Pharmacother"},{"key":"2020071613333519800_R6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/BF03349663","article-title":"Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil.","volume":"13","author":"Hayashida","year":"1990","journal-title":"J Endocrinol Invest"},{"key":"2020071613333519800_R7","first-page":"17","article-title":"Unusual complications of antithyroid drug therapy: four case reports and review of literature.","volume":"1","author":"Baker","year":"1989","journal-title":"Thyroidology"},{"key":"2020071613333519800_R8"},{"key":"2020071613333519800_R9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00005176-198809000-00027","article-title":"Propylthiouracil hepatotoxicity: two pediatric cases and review of the literature.","volume":"7","author":"Jonas","year":"1988","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2020071613333519800_R10","first-page":"353","article-title":"Propylthiouracil-induced cholestatic jaundice.","volume":"24","author":"Seidman","year":"1986","journal-title":"Clin Toxicol"},{"key":"2020071613333519800_R11","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/archinte.1985.00360110205048","article-title":"Propylthiouracil-associated hepatitis.","volume":"145","author":"Bloch","year":"1985","journal-title":"Arch Intern Med"},{"key":"2020071613333519800_R12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1177\/106002808501901009","article-title":"Hepatitis associated with propylthiouracil treatment.","volume":"19","author":"Garty","year":"1985","journal-title":"Drug Intell Clin Pharmacy"},{"key":"2020071613333519800_R13","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archinte.1984.00350170148025","article-title":"Propylthiouracil and hepatitis: two cases and a review of the literature.","volume":"144","year":"1984","journal-title":"Arch Intern Med"},{"key":"2020071613333519800_R14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF03350541","article-title":"Multiple complications of propylthiouracil treatment: granulocytopenia, eosinophilia, skin reaction, and hepatitis with lymphocyte sensitization.","volume":"5","author":"Pacini","year":"1982","journal-title":"J Endocrinol Invest"},{"key":"2020071613333519800_R15","first-page":"1471","article-title":"Propylthiouracil-induced hepatotoxicity.","volume":"1","year":"1982","journal-title":"Clin Pharmacol"},{"key":"2020071613333519800_R16","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1001\/archinte.1980.00330200060021","article-title":"Propylthiouracil-induced hepatic damage.","volume":"140","author":"Weiss","year":"1980","journal-title":"Arch Intern Med"},{"key":"2020071613333519800_R17","first-page":"1185","article-title":"Propythiouracil and hepatitis: a case report.","volume":"71","year":"1979","journal-title":"Journal of The National Medical Association"},{"key":"2020071613333519800_R18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0016-5085(76)80273-9","article-title":"Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil.","volume":"70","author":"Mihas","year":"1976","journal-title":"Gastroenterology"},{"key":"2020071613333519800_R19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.7326\/0003-4819-82-2-228_2","article-title":"Hepatitis and propylthiouracil.","volume":"82","year":"1975","journal-title":"Ann Intern Med"},{"key":"2020071613333519800_R20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archinte.1975.00330020123017","article-title":"Liver disease caused by propylthiouracil.","volume":"135","author":"Fedotin","year":"1975","journal-title":"Arch Intern Med"},{"key":"2020071613333519800_R21","first-page":"152","article-title":"Propylthiouracil-induced fatal hepatic necrosis.","volume":"82","author":"Limaye","year":"1987","journal-title":"Am J Gastroenterol"},{"key":"2020071613333519800_R22","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/archinte.1982.00340170198033","article-title":"Fatal propylthiouracil-induced hepatitis.","volume":"142","author":"Safani","year":"1982","journal-title":"Arch Intern Med"},{"key":"2020071613333519800_R23","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJM195311122492007","article-title":"Fulminant hepatitis during treatment with propylthiouracil.","volume":"249","year":"1953","journal-title":"N Engl J Med"},{"key":"2020071613333519800_R24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.1952.62930080001013","article-title":"Propylthiouracil-induced agranulocytosis, tosic hepatitis, and death.","volume":"148","author":"Colwell","year":"1952","journal-title":"JAMA"},{"key":"2020071613333519800_R25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-0029-1211075","article-title":"Adverse effects related to antithyroid drugs and their dose regimen.","volume":"97","author":"Romaldini","year":"1991","journal-title":"Exp Clin Endocinol"},{"key":"2020071613333519800_R26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/archpedi.1981.02130260004003","article-title":"Hyperthyrodism in children: a reevaluation of treatment.","volume":"135","author":"Buckingham","year":"1981","journal-title":"Am J Dis Child"},{"key":"2020071613333519800_R27","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0016-5085(77)80042-5","article-title":"Drug-induced chronic liver disease.","volume":"72","author":"Maddrey","year":"1977","journal-title":"Gastroenterology"},{"key":"2020071613333519800_R28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-3476(70)80130-5","article-title":"Granulocytopenia, lupus-like syndrome and other complications of propylthiouracil therapy.","volume":"76","author":"Amrhein","year":"1970","journal-title":"J Pediatr"},{"key":"2020071613333519800_R29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/jama.1946.02870060001001","article-title":"Toxic manifestations of thiouracil therapy.","volume":"130","year":"1946","journal-title":"JAMA"},{"key":"2020071613333519800_R30","author":"Cooper","year":"1996"},{"key":"2020071613333519800_R31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7326\/0003-4819-118-6-199303150-00005","article-title":"Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism: a cohort study.","volume":"118","author":"Liaw","year":"1993","journal-title":"Ann Intern Med"},{"key":"2020071613333519800_R32","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198411223112106","article-title":"Antithyroid drugs.","volume":"311","year":"1984","journal-title":"N Engl J Med"},{"key":"2020071613333519800_R33","author":"Vanderpump","year":"1996"},{"key":"2020071613333519800_R34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0016-5085(89)90081-4","article-title":"Early indicators of prognosis in fulminant hepatic failure.","volume":"97","author":"O\u2019Grady","year":"1989","journal-title":"Gastroenterology"},{"key":"2020071613333519800_R35","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1136\/gut.32.Suppl.S86","article-title":"Acute liver failure","volume":"35","author":"Hughes","year":"1991","journal-title":"Gut."},{"key":"2020071613333519800_R36","author":"Gordon","year":"1995"},{"key":"2020071613333519800_R37","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/0016-5085(88)90011-X","article-title":"Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.","volume":"94","author":"O\u2019Grady","year":"1988","journal-title":"Gastroenterology"},{"key":"2020071613333519800_R38","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0002-9343(83)91010-0","article-title":"Elevated thyroxine levels due to increased thyroxine-binding globulin in acute hepatitis.","volume":"74","author":"Ross","year":"1983","journal-title":"Am J Med"},{"key":"2020071613333519800_R39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/thy.1995.5.435","article-title":"Reverse T3 does not reliably differentiate hypothyroid sick syndrome from euthyroid sick syndrome.","volume":"5","year":"1995","journal-title":"Thyroid"},{"key":"2020071613333519800_R40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1210\/edrv-3-2-164","article-title":"Alterations in thyroid function in patients with systemic illness: The \u201ceuthyroid sick syndrome.\u201d","volume":"3","author":"Wartofsky","year":"1982","journal-title":"Endocr Rev"},{"key":"2020071613333519800_R41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/jcem-49-1-63","article-title":"In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroidal illnesses.","volume":"49","author":"Chopra","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613333519800_R42","first-page":"1165","article-title":"Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids.","volume":"76","author":"Lim","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613333519800_R43","first-page":"670","article-title":"Influence of nonthyroidal illnesses on serum thyroid hormone indices in hyperthyroidism.","volume":"138","author":"Lum","year":"1983","journal-title":"West J Med"},{"key":"2020071613333519800_R44","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/00007611-198907000-00028","article-title":"Hyperthyroidism without elevated levels of thyroxine and triiodothyronine in a patient with pulmonary tuberculosis.","volume":"82","author":"Archambeaud-Mouveroux","year":"1989","journal-title":"South Med J"},{"key":"2020071613333519800_R45","author":"Wartofsky","year":"1996"},{"key":"2020071613333519800_R46","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2265.1992.tb02267.x","article-title":"The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement.","volume":"36","author":"Philippou","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613333519800_R47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/jcem-40-1-33","article-title":"Serum thyroxine and triiodothyronine concentrations during iodide treatment of hyperthyroidism.","volume":"40","author":"Emerson","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613333519800_R48","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJM198712033172301","article-title":"Long-term treatment of alcoholic liver disease with propylthiouracil.","volume":"317","author":"Orrego","year":"1987","journal-title":"N Engl J Med"},{"key":"2020071613333519800_R49","first-page":"1071","article-title":"Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study.","volume":"89","author":"Huang","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"2020071613333519800_R50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/0003-4819-90-2-164","article-title":"Alkaline phosphatase isoenzyme patterns in hyperthyroidism.","volume":"90","author":"Cooper","year":"1979","journal-title":"Ann Intern Med"},{"key":"2020071613333519800_R51","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/clinchem\/35.7.1427","article-title":"Alkaline phosphatase isoenzymes in plasma in hyperthyroidism.","volume":"357","author":"Tibi","year":"1989","journal-title":"Clin Chem"},{"key":"2020071613333519800_R52","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1172\/JCI102338","article-title":"A correlative study of the cardiac output and the hepatic circulation in hyperthyroidism.","volume":"29","author":"Myers","year":"1950","journal-title":"J Clin Invest"},{"key":"2020071613333519800_R53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1152\/ajplegacy.1952.170.1.81","article-title":"Metabolism of tissues excised from thyroxine-injected rats.","volume":"170","author":"Barker","year":"1952","journal-title":"Am J Physiol"},{"key":"2020071613333519800_R54","first-page":"1083","article-title":"Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole.","volume":"80","author":"Arab","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613333519800_R55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00004836-198902000-00025","article-title":"Carbimazole-induced acute cholestatic hepatitis.","volume":"11","author":"Ozenne","year":"1989","journal-title":"J Clin Gastroenterol"},{"key":"2020071613333519800_R56","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archinte.146.7.1455a","article-title":"Carbimazole-induced cholestatic hepatitis.","volume":"146","author":"Ayensa","year":"1986","journal-title":"Arch Intern Med"},{"key":"2020071613333519800_R57","first-page":"244","article-title":"Methimazole-associated cholestatic liver injury: case report and brief literature review.","volume":"33","author":"Schmidt","year":"1986","journal-title":"Hepatogastroenterology"},{"key":"2020071613333519800_R58","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archinte.1985.00360080195029","article-title":"A case of Carbimazole-induced intraheptic cholestasis: an immune-mediated reaction?","volume":"145","author":"Blom","year":"1985","journal-title":"Arch Intern Med"},{"key":"2020071613333519800_R59","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJM198308183090725","article-title":"Postanesthetic carbimazole jaundice.","volume":"309","author":"Dinsmore","year":"1983","journal-title":"N Engl J Med"},{"key":"2020071613333519800_R60","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/gut.16.11.913","article-title":"Jaundice due to carbimazole.","volume":"16","author":"Lunzer","year":"1975","journal-title":"Gut"},{"key":"2020071613333519800_R61","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jama.1973.03220090048010","article-title":"Methimazole-induced jaundice.","volume":"223","author":"Fischer","year":"1973","journal-title":"JAMA"},{"key":"2020071613333519800_R62","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0016-5085(19)35060-7","article-title":"Drug-induced hepatic injury duing methimazole therapy.","volume":"43","author":"Martinez-Lopez","year":"1962","journal-title":"Gastroenterology"},{"key":"2020071613333519800_R63","first-page":"701","article-title":"Jaundice during methimazole administration.","volume":"42","year":"1953","journal-title":"Ann Intern Med"},{"key":"2020071613333519800_R64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/jama.1953.63690010003007b","article-title":"Agranulocytosis and toxic hepatitis from methimazole.","volume":"152","author":"Rosenbaum","year":"1953","journal-title":"JAMA"},{"key":"2020071613333519800_R65","first-page":"306","article-title":"Toxic hepatitis during treatment with methimazole: report of a case with apparent recovery.","volume":"58","author":"Tennenbaum","year":"1962","journal-title":"Ohio State Med J"},{"key":"2020071613333519800_R66","first-page":"473","article-title":"Toxic hepatitis induced by antithyroid drugs: four cases including one with cross-reactivity between carbimazole and benzylthiouracil.","volume":"2","author":"Sadoul","year":"1993","journal-title":"Eur J Med"},{"key":"2020071613333519800_R67"},{"key":"2020071613333519800_R68","first-page":"318","article-title":"Intrahepatic cholestasis in hyperthyroidism and the effect of antithyroid and beta-blocking drugs.","volume":"25","author":"Jansen","year":"1982","journal-title":"Neth J Med"},{"key":"2020071613333519800_R69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3904\/kjim.1990.5.1.69","article-title":"A case of methimazole-induced acute hepatic failure in a patient with chronic hepatitis B carrier.","volume":"5","author":"Kang","year":"1990","journal-title":"Korean J Intern Med"},{"key":"2020071613333519800_R70","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.1968.03150080067019","article-title":"Hepatitis from methimazole during adrenal steroid therapy for malignant exopthalmos.","volume":"206","author":"Becker","year":"1968","journal-title":"JAMA"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/82\/6\/1727\/10401285\/jcem1727.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/82\/6\/1727\/10401285\/jcem1727.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:07:27Z","timestamp":1594944447000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/82\/6\/1727\/2656370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6,1]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.82.6.4011","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,6,1]]}}}